Kiaro Holdings Corp.
Kiaro Holdings Corp.
Your view on KIARF
Overview
What the company does, where it operates, and who runs it.
About Kiaro Holdings Corp.
- Industry
- Medical - Pharmaceuticals
- Sector
- Healthcare
- CEO
- David Jenkins
- Headquarters
- 110 East Cordova Street, Vancouver, BC, CA
- Industry
- Medical - Pharmaceuticals
- Sector
- Healthcare
- CEO
- David Jenkins
- Headquarters
- 110 East Cordova Street, Vancouver, BC, CA
Kiaro Holdings Corp. owns and operates cannabis retail stores in Canada. It operates through three segments: Retail Cannabis Stores, Wholesale Cannabis Business, and eCommerce. The company offers cannabis and cannabis related products.
The company also operates an eCommerce platform that offers consumption accessories in Canada, the United States, and Australia; and engages in the wholesale of cannabis products to other licensed retailers in Saskatchewan.
It sells its products through a network of seventeen stores in British Columbia, Saskatchewan, and Ontario, as well as online. Kiaro Holdings Corp. is headquartered in Vancouver, Canada.
Media
Infographics, videos, and posts covering the company.
Stock Data
Price chart, volume, and trading data.
Fair Value
What FRC thinks it is worth vs. the current price.
FRC's fair value estimate for Kiaro Holdings Corp., and the rating behind it. KIARF last traded at $0.0000; the estimate is read against that market price. FRC analysts run the firm's valuation model across the companies on this platform to estimate what each one is worth, rather than republishing a consensus average. Shows the current estimate, our rating, and when it was last revised. A free account covers 7 company valuations a month; a paid subscription is unlimited.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
Valuation, profitability, liquidity and leverage ratios for Kiaro Holdings Corp.. Starting points for Kiaro Holdings Corp.: EPS -$0.42, beta 1.57 — an Medical - Pharmaceuticals name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
Dividend history, yield and payout sustainability for Kiaro Holdings Corp.. Kiaro Holdings Corp. does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
Reported vs. expected earnings history for Kiaro Holdings Corp.. Trailing twelve-month EPS for Kiaro Holdings Corp. stands at -$0.42. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Financial Statements
Income statement, balance sheet, and cash flow statements.
Income statement, balance sheet and cash flow history for Kiaro Holdings Corp.. Kiaro Holdings Corp. has reported as a listed company since 2021. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
Kiaro Holdings Corp. valued side by side against its closest peers. Kiaro Holdings Corp. is measured against Medical - Pharmaceuticals peers within the Healthcare sector. Peer-relative multiples and operating metrics, so the valuation is read in the context of its own sector rather than in isolation.
Institutional Ownership
PremiumWhich funds and firms own the stock.
Which institutions hold Kiaro Holdings Corp., and how their positions are changing. At a $442 market value, institutional positions materially move Kiaro Holdings Corp.'s register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings. Included with FRC Premium.
Insider Trading
PremiumRecent buying and selling by company executives.
Buying and selling by Kiaro Holdings Corp. executives and directors. Shares of Kiaro Holdings Corp. have traded between $0.0000 and $0.0051 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned. Included with FRC Premium.
Senate Trading
PremiumU.S. Senator disclosures filed under the STOCK Act.
U.S. Senate disclosures naming Kiaro Holdings Corp.. Kiaro Holdings Corp. is a $442 Healthcare company. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely. Included with FRC Premium.
House Trading
PremiumU.S. Representative disclosures filed under the STOCK Act.
U.S. House of Representatives disclosures naming Kiaro Holdings Corp.. Representatives' reported transactions in this security, shown next to the company's fundamentals. Included with FRC Premium.
News
Latest headlines and market coverage.
Latest headlines and company announcements for Kiaro Holdings Corp.. Coverage tracks Kiaro Holdings Corp. within Medical - Pharmaceuticals (Healthcare). Press releases and market coverage, newest first.